IFNG and chronic granulomatous disease: In addition, IFN-γ immunotherapy has been associated with faster clearance of Cryptococcus neoformans from the cerebrospinal fluid of HIV-1-infected AIDS patients; it also results in decreased incidence of infection or severity of invasive C. albicans infection in patients with chronic granulomatous disease (CGD) relative to untreated controls [27,28].